Boston Scientific Corporation (BSX) vs Moderna, Inc. (MRNA)
A side-by-side comparison of Boston Scientific Corporation and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.
BSX
Boston Scientific Corporation
$42.60HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
MRNA
Moderna, Inc.
$190.01HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT
Total return — BSX vs MRNA
growth of $100 · dividends reinvested · last 8yBSX +20.1% (+2.3%/yr)MRNA +921.6% (+33.7%/yr)MRNA compounded faster over this window
Log scale — wide-divergence pair
BSX MRNA
BSX vs MRNA: by the numbers
- •MRNA is the larger company ($75.39B vs $63.32B market cap).
- •BSX is profitable (17.47% net margin) while MRNA runs a net loss (-141.43%).
- •MRNA grew revenue faster over the past five years (19.33% vs 13.40% CAGR).
Metrics side by side
Valuation
| Metric | BSX | MRNA |
|---|---|---|
| P/E ratio | 17.32 | N/A |
| Forward P/E | 13.03 | N/A |
| PEG ratio | 0.58 | N/A |
| P/S ratio | 3.02 | 33.84 |
| P/B ratio | 2.54 | 11.15 |
| EV / EBITDA | 13.01 | N/A |
| FCF yield | 5.72% | N/A |
Profitability
| Metric | BSX | MRNA |
|---|---|---|
| Gross margin | 71.16% | 55.35% |
| Operating margin | 21.46% | -158.13% |
| Net margin | 17.47% | -141.43% |
| ROE | 14.71% | -46.61% |
| ROIC | 10.57% | -39.16% |
Growth (annualized)
| Metric | BSX | MRNA |
|---|---|---|
| Revenue CAGR (5Y) | 13.40% | 19.33% |
| EPS CAGR (5Y) | 29.71% | N/A |
| FCF CAGR (5Y) | 15.64% | N/A |
| Total return CAGR (5Y) | 0.09% | -11.04% |
Frequently asked
- Which has grown faster, BSX or MRNA?
- Over the past five years, MRNA grew revenue faster — BSX at a 13.40% CAGR versus MRNA at 19.33%.
- Is BSX or MRNA more profitable?
- BSX runs the higher net margin — BSX at 17.47% versus MRNA at -141.43%.
- How have BSX and MRNA total returns compared?
- Over the past 5 years, BSX delivered 0.09% and MRNA delivered -11.04% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Boston Scientific P/E ratioBoston Scientific ROEModerna ROEBoston Scientific operating marginModerna operating marginBoston Scientific revenue growthModerna revenue growthBoston Scientific free cash flowModerna free cash flow
Boston Scientific & Moderna appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.